Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
inosine + tocopherol + tocotrienol + coenzyme Q10 + niacinamide + vitamin C + N-acetyl cysteine + multivitamin + minocycline
- Development stage
- Unknown
- Lead developer
- Mid-Atlantic Retina Consultations
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination therapy is a multi-ingredient nutritional and pharmaceutical regimen investigated as an adjunctive treatment for diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Developed by Mid-Atlantic Retina Consultations, Inc., the cocktail combines the tetracycline antibiotic minocycline with a specific array of dietary supplements, including inosine, various forms of vitamin E (tocopherols and tocotrienols), coenzyme Q10, niacinamide, vitamin C, N-acetyl cysteine, and a complete multivitamin. The rationale behind this combination is to leverage the anti-inflammatory and neuroprotective properties of minocycline alongside the antioxidant and metabolic support provided by the supplements to improve clinical outcomes in retinal vascular diseases. Several components are administered in sustained-release formulations to maintain consistent therapeutic levels.
- Other names
- Supplements and Minocycline for DME and NAMDSAINTS
02
Targets
GSH (Glutathione)NAD (Nicotinamide adenine dinucleotide)MMP12 (Macrophage Metalloelastase)
Beyond the preview
Go deeper on inosine + tocopherol + tocotrienol + coenzyme Q10 + niacinamide + vitamin C + N-acetyl cysteine + multivitamin + minocycline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on inosine + tocopherol + tocotrienol + coenzyme Q10 + niacinamide + vitamin C + N-acetyl cysteine + multivitamin + minocycline.